Cargando…
Evaluation of drug mechanism and efficacy of a novel anti-angiogenic agent, TTAC-0001, using multi-modality bioimaging in a mouse breast cancer orthotopic model
PURPOSE: Targeting of vascular endothelial growth factor receptors (VEGFRs) has potential anti-angiogenic effects because VEGFR-2 is the major signaling regulator of VEGF/VEGFR pathways. We aimed to elucidate the drug mechanism and anti-tumor efficacy of TTAC-0001, a novel, fully human anti-VEGFR-2/...
Autores principales: | Kim, Jinil, Choi, Sang Hyun, Ham, Su Jung, Cho, Young Chul, Lee, Seul-I, Kang, Jeeheon, Woo, Dong-Cheol, Lee, Weon Sub, Yoo, Jin-San, Kim, Kyung Won, Choi, Yoonseok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784895/ https://www.ncbi.nlm.nih.gov/pubmed/29370209 http://dx.doi.org/10.1371/journal.pone.0187063 |
Ejemplares similares
-
Preclinical pharmacokinetics, interspecies scaling, and pharmacokinetics of a Phase I clinical trial of TTAC-0001, a fully human monoclonal antibody against vascular endothelial growth factor 2
por: Lee, Weon Sup, et al.
Publicado: (2018) -
Anticancer activity of TTAC-0001, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) monoclonal antibody, is associated with inhibition of tumor angiogenesis
por: Kim, Dong Geon, et al.
Publicado: (2015) -
Magnetic Resonance Colonography Enables the Efficacy Assessment of Immune Checkpoint Inhibitors in an Orthotopic Colorectal Cancer Mouse Model()()
por: Chae, Yeon Ji, et al.
Publicado: (2019) -
The administration of hydrogen sulphide prior to ischemic reperfusion has neuroprotective effects in an acute stroke model
por: Woo, Chul-Woong, et al.
Publicado: (2017) -
Adsorption and Dissociation of CO(2) on Ru(0001)
por: Pachecka, M., et al.
Publicado: (2017)